Clinical Trials Logo

Clinical Trial Summary

Extend evaluation of deferasirox film-coated tablet (FCT) formulation


Clinical Trial Description

Collection of additional safety and efficacy data with deferasirox film-coated tablet (FCT) in patients who had completed study CICL670F2201

- Provide patients who completed 24 weeks of treatment in the core study, CICL670F2201, the possibility to have additional treatment with the deferasirox FCT.

- Collect additional longer term data on the safety and the tolerability of the deferasirox FCT.

- Collect efficacy data on the deferasirox FCT in reduction or maintenance of iron burden as measured by serum ferritin level. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02720536
Study type Interventional
Source Novartis
Contact
Status Completed
Phase Phase 3
Start date August 16, 2016
Completion date July 23, 2019

See also
  Status Clinical Trial Phase
Completed NCT05440487 - Study to Assess Iron Chelation Therapy in Patients With Chronic Iron Overload
Completed NCT01825512 - Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients Phase 3
Completed NCT06215287 - Survey to Assess Physicians' Knowledge of Exjade Posology and Biological Monitoring Recommendations as Described in the Educational Materials
Completed NCT01740713 - Pharmacokinetic Study of Deferiprone in Paediatric Patients Phase 2